{
    "LeadSponsorName": [
        "Basilea Pharmaceutica",
        "Agenus Inc.",
        "Genentech, Inc.",
        "Eli Lilly and Company",
        "R-Pharm International, LLC",
        "HUYABIO International, LLC.",
        "Biocinese",
        "Cellectar Biosciences, Inc.",
        "Bioverativ Therapeutics Inc.",
        "Eurofarma Laboratorios S.A.",
        "NovoCure Ltd.",
        "Brooklyn ImmunoTherapeutics, LLC",
        "Celldex Therapeutics",
        "OncoVerity, Inc.",
        "Kronos Bio",
        "Janssen Pharmaceutica N.V., Belgium",
        "Pierre Fabre Medicament",
        "Checkpoint Therapeutics, Inc.",
        "Apellis Pharmaceuticals, Inc.",
        "Aragon Pharmaceuticals, Inc.",
        "Telik",
        "Anthera Pharmaceuticals",
        "EMD Serono",
        "Arcus Biosciences, Inc.",
        "Geron Corporation",
        "Helsinn Healthcare SA",
        "Celcuity, Inc.",
        "CancerVax Corporation",
        "RECORDATI GROUP",
        "Crinetics Pharmaceuticals Inc.",
        "medac GmbH",
        "F2G Biotech GmbH",
        "Baxalta now part of Shire",
        "EMD Serono Research & Development Institute, Inc.",
        "Shire",
        "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
        "Merck KGaA, Darmstadt, Germany",
        "Libbs Farmac\u00eautica LTDA",
        "Applied Biology, Inc.",
        "Takeda",
        "Janssen Vaccines & Prevention B.V.",
        "Janssen Research & Development, LLC",
        "Debiopharm International SA",
        "Becton, Dickinson and Company",
        "Clovis Oncology, Inc.",
        "Sumitomo Pharma Oncology, Inc.",
        "Mirati Therapeutics Inc.",
        "Loxo Oncology, Inc.",
        "PTC Therapeutics",
        "Zodiac Produtos Farmaceuticos S.A.",
        "Taiho Oncology, Inc.",
        "Astellas Pharma Global Development, Inc.",
        "Tobira Therapeutics, Inc.",
        "ISA Pharmaceuticals",
        "Daiichi Sankyo, Inc.",
        "Novo Nordisk A/S",
        "Telios Pharma, Inc.",
        "Viracta Therapeutics, Inc.",
        "Biozeus Biopharmaceutical S.A.",
        "Humanigen, Inc.",
        "Sesen Bio, Inc.",
        "Otsuka Pharmaceutical Development & Commercialization, Inc.",
        "Mallinckrodt",
        "Merck Sharp & Dohme LLC",
        "Azidus Brasil",
        "Tularik",
        "Asahi Kasei Pharma America Corporation",
        "Acerta Pharma BV",
        "Biogen",
        "ApoPharma",
        "Millennium Pharmaceuticals, Inc.",
        "Cogent Biosciences, Inc.",
        "Guerbet",
        "Recombio SL",
        "Alexion",
        "Novartis",
        "Cryopraxis Criobiologia Ltda.",
        "Threshold Pharmaceuticals",
        "Sanofi",
        "Ipsen",
        "AstraZeneca",
        "Chiltern Pesquisa Clinica Ltda",
        "Novartis Pharmaceuticals",
        "Exelixis",
        "AVEO Pharmaceuticals, Inc.",
        "mAbxience Research S.L.",
        "Eisai Inc.",
        "UCB BIOSCIENCES GmbH",
        "Kyowa Kirin, Inc.",
        "Ultragenyx Pharmaceutical Inc",
        "Sandoz",
        "Astellas Pharma Inc",
        "Spectrum Pharmaceuticals, Inc",
        "Algenis SpA",
        "Isarna Therapeutics GmbH",
        "Myovant Sciences GmbH",
        "Bayer",
        "pharmaand GmbH",
        "Janssen Pharmaceutica",
        "bluebird bio",
        "GlaxoSmithKline",
        "Lavilabor Natural Products Ltd",
        "Morphotek",
        "Advaxis, Inc.",
        "BeiGene",
        "Gamida Cell ltd",
        "Janssen-Cilag Farmaceutica Ltda.",
        "ViiV Healthcare",
        "Nereus Pharmaceuticals, Inc.",
        "Tolmar Inc.",
        "Eidos Therapeutics, a BridgeBio company",
        "Immune Biosolutions Inc",
        "Human Genome Sciences Inc., a GSK Company",
        "Janssen Sciences Ireland UC",
        "PharmaMar",
        "Active Biotech AB",
        "NantCell, Inc.",
        "Alaunos Therapeutics",
        "Nektar Therapeutics",
        "Corcept Therapeutics",
        "Heidelberg Pharma AG",
        "Sophia Genetics SAS",
        "Seagen Inc.",
        "Incyte Corporation",
        "Immix Biopharma, Inc.",
        "SciClone Pharmaceuticals",
        "CSL Behring",
        "Jazz Pharmaceuticals",
        "Celgene",
        "Ligand Pharmaceuticals",
        "Boston Scientific Corporation",
        "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.",
        "Amgen",
        "ColubrisMX",
        "Bristol-Myers Squibb",
        "Repros Therapeutics Inc.",
        "Akeso",
        "AbbVie",
        "Janssen Scientific Affairs, LLC",
        "Shionogi",
        "BioNTech SE",
        "Scitech Produtos Medicos Ltda",
        "Wyeth is now a wholly owned subsidiary of Pfizer",
        "Boehringer Ingelheim",
        "AbbVie (prior sponsor, Abbott)",
        "Vical",
        "Synta Pharmaceuticals Corp.",
        "Principia Biopharma, a Sanofi Company",
        "Recepta Biopharma",
        "OBI Pharma, Inc",
        "UCB Pharma",
        "Gilead Sciences",
        "Tesaro, Inc.",
        "Abivax S.A.",
        "Puma Biotechnology, Inc.",
        "Janssen-Cilag Ltd.",
        "BioMarin Pharmaceutical",
        "Genzyme, a Sanofi Company",
        "Intercept Pharmaceuticals",
        "Regeneron Pharmaceuticals",
        "Crist\u00e1lia Produtos Qu\u00edmicos Farmac\u00eauticos Ltda.",
        "CanariaBio Inc.",
        "OSI Pharmaceuticals",
        "Uni\u00e3o Qu\u00edmica Farmac\u00eautica Nacional S/A",
        "R-Pharm",
        "Kartos Therapeutics, Inc.",
        "Xcovery Holding Company, LLC",
        "Merrimack Pharmaceuticals",
        "RayzeBio, Inc.",
        "Agios Pharmaceuticals, Inc.",
        "Teva Branded Pharmaceutical Products R&D, Inc.",
        "Inovio Pharmaceuticals",
        "EOM Pharmaceuticals",
        "Halozyme Therapeutics",
        "Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",
        "Genmab",
        "Polyphor Ltd.",
        "Pfizer",
        "Mylan Inc.",
        "Hoffmann-La Roche",
        "Abbott"
    ]
}